Please login to the form below

Not currently logged in

Lucid Group secures new investment from Intermediate Capital Group

ICG will support further expansion for Lucid across the globe, in particular in the US

Healthcare communications company Lucid Group has announced that it has secured new investment from Intermediate Capital Group (ICG).

Private equity firm LDC will end its investment in Lucid after nearly four years, during which time Lucid has successfully completed two acquisitions – HealthCare21 and Bluedog.

Lucid has also expanded into new markets, including Singapore and Dubai, and also made additions to its presence in the US.

Lucid’s new investment from asset manager ICG will support its ambitions to acquire and build new capabilities, as well as attract new talent and evolve its people development offering, the health communications company said in a statement.

ICG will also support further expansion for Lucid across the globe, in particular in the US.

“This marks the start of an exciting new chapter for Lucid, which drives increased investment to help us realise our vision of transforming lives,” said Dennis O’Brien, chief executive officer, Lucid Group.

“We have a tremendous team and a great client base, and our goal is to continue to strengthen this by bringing new capabilities and more value to our partnerships. With ICG we feel we have the perfect partner who shares our vision and matches our level of ambition to transform the value we bring to our industry and to patients,” he added.

“ICG is a leading global alternative asset manager, with a long and successful track record of providing capital to support founder-led growing businesses like Lucid Group,” said Peter Kirtley, managing director, ICG.

“We have admired Lucid Group and its reputation within the industry for many years. Through our partnership, together, we can leverage Lucid’s ambition and our sector expertise to build a truly global healthcare communications organisation,” he added.

Article by
Lucy Parsons

11th March 2021

From: Marketing


COVID-19 Updates and Daily News

Featured jobs


Add my company
Frontera Group

A leading global patient-activation group - comprising of a digital insight consultancy, creative activation agency. Our foundations lie in behavioural...

Latest intelligence

How can we strike the right balance between familiarity and innovation when it comes to data presentation?
Following our webinar in March, Getting MedComms right: navigating the age of the amateur expert, we’re taking the time to respond to questions we were unable to answer during the...
Deep 6 AI: the smart software breathing new life into clinical trials
Fishawack Health interviews Wout Brusselaers, the Deep 6 AI CEO using artificial intelligence to solve one of the greatest barriers stagnating healthcare innovation—clinical trial recruitment and retention....
COVID-proof: How Teams are Creating Launch Intensity thru Adversity
Now that the game has changed, how are marketers shifting their launch behaviour? We've identified 5 common observations from effective teams....